LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,098 | -16.9% | 35 | 0.0% | 0.00% | – |
| Q2 2023 | $2,524 | -2.0% | 35 | 0.0% | 0.00% | – |
| Q1 2023 | $2,575 | +10.1% | 35 | 0.0% | 0.00% | – |
| Q4 2022 | $2,338 | -22.1% | 35 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 35 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 35 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 35 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 35 | -58.8% | 0.00% | – |
| Q3 2020 | $8,000 | -33.3% | 85 | -21.3% | 0.00% | -100.0% |
| Q2 2020 | $12,000 | +50.0% | 108 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | 0.0% | 108 | +38.5% | 0.00% | – |
| Q4 2019 | $8,000 | 0.0% | 78 | -8.2% | 0.00% | – |
| Q3 2019 | $8,000 | -33.3% | 85 | -19.8% | 0.00% | -100.0% |
| Q2 2019 | $12,000 | -7.7% | 106 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | 0.0% | 106 | +7.1% | 0.00% | 0.0% |
| Q4 2018 | $13,000 | -51.9% | 99 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $27,000 | +3.8% | 99 | -22.0% | 0.00% | 0.0% |
| Q2 2018 | $26,000 | +36.8% | 127 | +8.5% | 0.00% | +100.0% |
| Q1 2018 | $19,000 | -34.5% | 117 | -44.5% | 0.00% | -50.0% |
| Q4 2017 | $29,000 | 0.0% | 211 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $29,000 | +11.5% | 211 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $26,000 | -45.8% | 211 | -53.4% | 0.00% | -33.3% |
| Q1 2017 | $48,000 | +6.7% | 453 | +1.8% | 0.00% | 0.0% |
| Q4 2016 | $45,000 | -11.8% | 445 | -11.7% | 0.00% | -25.0% |
| Q3 2016 | $51,000 | -15.0% | 504 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $60,000 | +11.1% | 501 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $54,000 | +8.0% | 505 | +8.6% | 0.00% | 0.0% |
| Q4 2015 | $50,000 | +117.4% | 465 | +69.7% | 0.00% | +100.0% |
| Q3 2015 | $23,000 | -25.8% | 274 | -11.0% | 0.00% | 0.0% |
| Q2 2015 | $31,000 | +47.6% | 308 | +11.2% | 0.00% | 0.0% |
| Q1 2015 | $21,000 | +40.0% | 277 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $15,000 | +7.1% | 277 | -6.1% | 0.00% | 0.0% |
| Q3 2014 | $14,000 | +600.0% | 295 | +742.9% | 0.00% | – |
| Q2 2014 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2014 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |